My clinical service and academic interests focus on implementing new tests for in vitro diagnosis and to improve quality of testing by promoting excellence in automation, toxicology and point of care areas of laboratory.

Dr. Budelier is an Instructor in Pathology and Immunology at Washington University in St Louis, and is a Co-Medical Director of the Barnes Jewish Hospital Toxicology Laboratory. Her research interests are broadly focused on developing clinically useful, mass spectrometry-based assays to improve diagnosis and treatment of human disease. Her expertise are in Toxicology/TDM, assay development and validation, and protein quantification.

Dustin R. Bunch, PhD, DABCC, is the assistant director of Clinical Chemistry and Laboratory Informatics at Nationwide Children's Hospital. He is board certified by The Commission on Accreditation in Clinical Chemistry (ComACC) in clinical chemistry and completed his clinical chemistry fellowship at Yale-New Haven Hospital/Yale University in Jun 2019. He received his PhD in Clinical/Bioanalytical Chemistry from Cleveland State University in 2016 and BA in Biochemistry from Case Western Reserve University in 2004. Over the years his research has focused mainly on development and validation of liquid chromatography tandem mass spectrometry (LC-MS/MS) methods; however, recently he has been performing research on hospital and clinical informatics. He is active in professional organizations (AACC, ASCP, and MSACL) for both the local and national level serving on boards and committees.

Pankaj has expertise in cancer biology, quantitative proteomics-phosphoproteomics, protein biochemistry, and proteomics data analysis. He has published seminal scientific papers on the cytokine receptor biology and its role in leukemia. His sphere of experience and interest includes but not limited to cell cultures, mouse models, processing proteomics samples and operating nano-LC-MS/MS. He has in-depth knowledge and understanding of quantitative proteomics techniques, e.g. SILAC, TMT, iTRAQ and RABA and understanding of aberrant proteomics as well as phospho-signaling and global ubiquitin profiles of solid and liquid tumor models.

I started my career as a vascular surgeon back in Volgograd, Russia in 2007. However, it was science, that always excited me and after relocating to United States, I joined the lab studying vascular complication of chronic kidney disease. Gradually, I progressed to nephropathology and its microbiome aspect. That was the point when I joined the MassSpec team and fell in love with this technology. Nowadays, I can see how thousands of brilliant scientists use this tool in their research, making it truly exciting. And this is only beginning.

I have obtained a degree as an Engineer in Chemistry focusing on analytical biochemistry, followed by a masters and PhD in Biochemistry (SS Cyril and Methodius University, N Macedonia) with a major focus on clinical proteomics and MALDI mass spectrometry. I have furthered my experience in a clinical laboratory (Clinic of Neurology), academia (The Biodesign Institute, ASU) and Industry (HealthTell Inc ). I am fascinated by mass spectrometry and the unambiguity it possess. I am currently a Senior Scientist at Cowper Sciences Inc, where I am focusing on exploring/applying novel methods and techniques in proteomics research, with potential for operation and commercialization.